Skip to main content
Log in

Mycetoma

A Review

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Mycetoma is a chronic granulomatous infection that is present worldwide and endemic in tropical and subtropical regions. The infection is caused by the traumatic inoculation of a fungus (eumycetoma) or a bacterium (actinomycetoma) and generally remains localized, causing cutaneous and subcutaneous tissue swelling, nodule formation, and drainage through sinus tracts. This review details the history of mycetoma, which may date as far back as the Byzantine period (300–600 AD), the epidemiology of the disease, which is characterized by an endemic region located between the latitudes of 15° south and 30° north, and the clinical presentation and treatment of mycetoma, focusing on the differences between eumycete and actinomycete infections. Diagnosis is established by identifying the type of grains found in the discharge, which guides treatment. Mycetoma caused by bacteria can usually be managed effectively with antibacterial medication alone, while infections with fungi require antifungal medication and surgery. Without proper treatment, mycetoma can lead to deformity, amputation, and death.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Fig. 1
Table II
Table III
Table IV

Similar content being viewed by others

References

  1. Ahmed AO, van Leeuwen W, Fahal A, et al. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis. 2004 Sep; 4 (9): 566–74

    Article  PubMed  Google Scholar 

  2. Hay RJ. Deep fungal infections. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. 5th edition. Vol. 2. New York: McGraw-Hill; 1999: 2372–7

    Google Scholar 

  3. McGinnis MR. Mycetoma. Dermatol Clin. 1996 Jan; 14 (1): 97–104

    Article  PubMed  CAS  Google Scholar 

  4. Fahal AH. Mycetoma: a thorn in the flesh. Trans R Soc Trop Med Hyg. 2004 Jan; 98 (1): 3–11

    Article  PubMed  CAS  Google Scholar 

  5. Hershkovitz I, Speirs M, Katznelson A, et al. Unusual pathological condition in the lower extremities of a skeleton from ancient Israel. Am J Phys Anthropol. 1992 May; 88 (1): 23–6

    Article  PubMed  CAS  Google Scholar 

  6. Kwon-Chung KJ, Bennett JE. Mycetoma. In: Cann C, editor. Medical mycology. Malvern (PA): Lea & Febiger; 1992: 560–93

    Google Scholar 

  7. Corre A. La maladie de Ballingall (pied du Maduré). Arch Med Nav. 1883; 39 (81): 204–24

    Google Scholar 

  8. Godfrey J. Diseases of the foot not hitherto described. Lancet. 1846; 1: 593–4

    Google Scholar 

  9. Carter HV. On a new striking form of fungus disease principally affecting the foot and prevailing endemically in many parts of India. Trans Med Phys Soc Bombay. 1860; 60: 140–2

    Google Scholar 

  10. Pinoy E. Actinomycoses and mycetomas. Bull Inst Past. 1913; 11: 929–38

    Google Scholar 

  11. Fahal AH. Review article [online]. Khartoum: Mycetoma Research Center, 2000. Available from URL: http://www.myeetoma.org/updates.htm [Accessed 2006 Sep 12]

    Google Scholar 

  12. Green WO, Adams TE. Mycetoma in the United States. Am J Clin Path. 1964 Jul; 42: 75–91

    PubMed  Google Scholar 

  13. Tight RR, Bartlett MS. Actinomycetoma in the United States. Rev Infect Dis. 1981 Nov–Dec; 3 (6): 1139–50

    Article  PubMed  CAS  Google Scholar 

  14. Foltz KD, Fallat LM. Madura foot: atypical finding and case presentation. J Foot Ankle Surg. 2004 Sep–Oct; 43 (5): 327–31

    Article  PubMed  Google Scholar 

  15. Rigopoulos D, Mavridou M, Nicolaidou E, et al. Mycetoma due to actinomycetes: a rare entity in Europe. Int J Dermatol. 2000 Jul; 39 (7): 557–8

    Article  PubMed  CAS  Google Scholar 

  16. De Palma L, Marinelli M, Pavan M, et al. A rare European case of Madura foot due to actinomycetes. Joint Bone Spine. 2006 May; 73 (3): 321

    Article  PubMed  Google Scholar 

  17. Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol. 2005 Dec; 53 (6): 931–51

    Article  PubMed  Google Scholar 

  18. Maiti PK, Ray A, Bandyopadhyay S. Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal. Trop Med Int Health. 2002 Sep; 7 (9): 788–92

    Article  PubMed  CAS  Google Scholar 

  19. Welsh O, Vera-Cabrera L, Salinas-Carmona MC. Mycetoma [online]. New York: eMedicine.com, 2005. Available from URL: http://www.emedicine.com/derm/topic280.htm [Accessed 2006 Sep 12]

    Google Scholar 

  20. Khatri ML, Al-Halali HM, Fouad Khalid M. Mycetoma in Yemen: clinicoepidemiologic and histopathologic study. Int J Dermatol. 2002 Sep; 41 (9): 586–93

    Article  PubMed  Google Scholar 

  21. Abbott P. Mycetoma in the Sudan. Trans R Soc Trop Med Hyg. 1956 Jan; 50 (1): 11–30

    Article  PubMed  CAS  Google Scholar 

  22. Pang KR, Wu JJ, Huang DB. Subcutaneous fungal infections. Dermatol Ther. 2004; 17 (6): 523–31

    Article  PubMed  Google Scholar 

  23. Sobera JO, Elewski BE. Mycetoma. In: Bolognia JL, Jorizzo JL, Rapini RP, et al., editors. Dermatology. Vol. 1. New York: Mosby, 2003: 1187–8

    Google Scholar 

  24. Verdolini R, Amerio P, Bugatti L, et al. Madura’s foot: report of a case caused by Madurella mycetomatis. Fur J Dermatol. 2000 Dec; 10 (8): 627–9

    CAS  Google Scholar 

  25. Turner PG. Madura foot or plantar fibromatosis. J Bone Joint Surg Br. 1989 May; 71 (3): 531

    PubMed  CAS  Google Scholar 

  26. Fahal AH, et Hassan AM, Abdelalla AO, et al. Cystic mycetoma: an unusual clinical presentation of Madurella mycetomatis infection. Trans R Soc Trop Med Hyg. 1998 Jan–Feb; 92 (1): 66–7

    Article  PubMed  CAS  Google Scholar 

  27. Richardson MD, Warnock DW. Mycetoma. In: Richardson MD, Warnock DW. Fungal infection diagnosis and management. 2nd ed. Malden (MA): Blackwell Science, Inc., 1997: 204–9

    Google Scholar 

  28. Boiron P, Locci R, Goodfellow M, et al. Nocardia, nocardiosis and mycetoma. Med Mycol. 1998; 36 Suppl. 1: 26–37

    PubMed  Google Scholar 

  29. Fahal AH. Evidence based guidelines for mycetoma patients’ management [online]. Khartoum: Mycetoma Research Center, 2000. Available from URL: http://www.myeetoma.org/updatesmanagment.htm [Accessed 2006 Sep 12]

    Google Scholar 

  30. Abd Bagi ME, Fahal AH, Sheik HE, et al. Pathological fractures in mycetoma. Trans R Soc Trop Med Hyg. 2003 Sep–Oct; 97 (5): 582–4

    Article  PubMed  CAS  Google Scholar 

  31. Sharif HS, Clark DC, Aabed MY, et al. Mycetoma: comparison of MR imaging with CT. Radiology. 1991 Mar; 178 (3): 865–70

    PubMed  CAS  Google Scholar 

  32. Czechowski J, Nork H, Haas D, et al. MR and other imaging methods in the investigation of mycetomas. Acta Radiol. 2001 Jan; 42 (1): 24–6

    Article  PubMed  CAS  Google Scholar 

  33. Yera H, Bougnox ME, Jeanrot C, et al. Mycetoma of the foot caused by Fusarium solani: identification of the etiologic agent by DNA sequencing. J Clin Microbiol. 2003 Apr; 41 (4): 1805–8

    Article  PubMed  CAS  Google Scholar 

  34. Ahmed A, Adelmann D, Fahal A, et al. Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan. J Clin Microbiol. 2002 Mar; 40 (3): 1031–6

    Article  PubMed  Google Scholar 

  35. Mahgoub ES, Gumaa SA. Ketoconazole in the treatment of eumycetoma due to Madurella mycetoma. Trans R Soc Trop Med Hyg. 1984; 78 (3): 376–9

    Article  PubMed  CAS  Google Scholar 

  36. Aiyenuro O, Nathan S. Mycetoma presenting as a painful ankle monoarthropathy: a case report. Foot Ankle Surg. 2006; 12: 43–6

    Article  Google Scholar 

  37. Mahgoub ES. Medical management of mycetoma. Bull World Health Organ. 1976; 54 (3): 303–10

    PubMed  CAS  Google Scholar 

  38. Welsh O, Sauceda E, Gonzalez J, et al. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. J Am Acad Dermatol. 1987 Sep; 17 (3): 443–8

    Article  PubMed  CAS  Google Scholar 

  39. Kashima M, Kano R, Mikami Y, et al. A successfully treated case of mycetoma due to Nocardia veterana. Br J Dermatol. 2005 Jun; 152 (6): 1349–52

    Article  PubMed  CAS  Google Scholar 

  40. Sharma N, Mendiratta V, Sharma RC, et al..Pulse therapy with amikacin and dapsone for the treatment of actinomycotic foot: a case report. J Dermatol. 2003 Oct; 30 (10): 742–7

    PubMed  Google Scholar 

  41. Fuentes A, Arenas R, Reyes M, et al..Actinomycetoma and Nocardia sp.: report of five cases treated with imipenem or imipenem plus amikacin [in Spanish]. Gac Med Mex. 2006 May–Jun; 142 (3): 247–52

    PubMed  Google Scholar 

  42. Gomez A, Saul A, Bonifaz A, et al..Amoxicillin and clavulanic acid in the treatment of actinomycetes. Int J Dermatol. 1993 Mar; 32 (3): 218–20

    Article  PubMed  CAS  Google Scholar 

  43. Ramam M, Garg T, D’Souza P, et al..A two-step schedule for the treatment of actinomycotic mycetomas. Acta Derm Venereol. 2000 Sep–Oct; 80 (5): 378–80

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors have no conflict of interests financially or otherwise with any subject matter discussed in this review. No sources of funding were used in the preparation of this review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amor Khachemoune.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lichon, V., Khachemoune, A. Mycetoma. Am J Clin Dermatol 7, 315–321 (2006). https://doi.org/10.2165/00128071-200607050-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200607050-00005

Keywords

Navigation